Olaratumab and Olopatadine nasal

• Generic Name: olaratumab
• Dosage Forms: n.a.
• Other Brand Names: Lartruvo

Olaratumab is a monoclonal antibody that blocks a certain type of cell receptor in the body that can affect tumor cell growth. Monoclonal antibodies are made to target and destroy only certain cells in the body, which may help slow or stop tumor growth.

Olaratumab is used in combination with another cancer medicine called doxorubicin, to treat adults with soft tissue sarcoma. Olaratumab is used when your condition cannot be treated with surgery or radiation.

Olaratumab was approved by the US Food and Drug Administration (FDA) on an "accelerated" basis. In clinical studies, olaratumab was shown to lengthen survival time. However, further studies are needed to determine if olaratumab is effective in larger numbers of patients with soft tissue sarcoma.

Olaratumab may also be used for purposes not listed in this medication guide.

• Generic Name: olopatadine nasal
• Dosage Forms: n.a.
• Other Brand Names: Patanase

Olopatadine nasal is an antihistamine that reduces the effects of natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.

Olopatadine nasal (for the nose) is used to treat symptoms such as congestion, sneezing, and runny nose caused by seasonal allergies. Olopatadine nasal is for use in adults and children who are at least 6 years old.

Olopatadine nasal may also be used for purposes not listed in this medication guide.